Akebia Therapeutics reported $38.68M in Gross Profit on Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US $ 112.52M 15.68M
Akebia Therapeutics AKBA:US $ 38.68M 21.44M
Alnylam Pharmaceuticals ALNY:US $ 177.63M 43.24M
Amgen AMGN:US $ 4677M 451M
Ardelyx ARDX:US $ 0.38M 0.65M
Astellas Pharma 4503:JP Y 244955M 26313M
AstraZeneca AZN:LN 9.11B 169M
Bayer BAYN:GR 9.46B 2.03B
Biomarin Pharmaceutical BMRN:US $ 402.39M 72.33M
Exelixis EXEL:US $ 342.78M 95.45M
Fresenius Medical Care FME:GR € 1258.1M 61.07M
GlaxoSmithKline GSK:LN 6.14B 283M
Intercept Pharmaceuticals ICPT:US $ 87.82M 3.57M
IONIS PHARMACEUT IONS:US $ 137.75M 300.03M
Johnson & Johnson JNJ:US $ 15828M 1021M
Karyopharm Therapeutics KPTI:US $ 46.24M 79.28M
Moderna Inc MRNA:US 5.05B 1.21B
Nektar Therapeutics NKTR:US $ 19.51M 0.66M
Opko Health OPK:US $ 85.34M 23.16M
Ptc Therapeutics PTCT:US $ 138.6M 17.3M
Regeneron Pharmaceuticals REGN:US $ 2560.2M 1408.9M
Sarepta Therapeutics SRPT:US $ 179.39M 9.67M
Seattle Genetics SGEN:US $ 338.83M 4.33M
Vanda Pharmaceuticals VNDA:US $ 54.53M 7.26M